Title:
RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION CONTAINING RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PREPARATION METHOD AND USE OF THE PHARMACEUTICAL COMPOSITION
Document Type and Number:
WIPO Patent Application WO/2019/000682
Kind Code:
A1
Abstract:
The invention relates to a Rho-associated protein kinase (ROCK) inhibitor of formula (I), a pharmaceutical composition containing said Rho-associated protein kinase inhibitor, a preparation method thereof and an application of the ROCK for treating and preventing rock-mediated disease.
Inventors:
ZHAO YANPING (CN)
WANG HONGJUN (CN)
LI GONG (CN)
JIANG YUANYUAN (CN)
LI XIANG (CN)
ZHOU LIYING (CN)
LIU YANAN (CN)
WANG HONGJUN (CN)
LI GONG (CN)
JIANG YUANYUAN (CN)
LI XIANG (CN)
ZHOU LIYING (CN)
LIU YANAN (CN)
Application Number:
PCT/CN2017/104290
Publication Date:
January 03, 2019
Filing Date:
September 29, 2017
Export Citation:
Assignee:
BEIJING TIDE PHARMACEUTICAL CO LTD (CN)
International Classes:
C07D403/12; A61K31/4155; A61K31/506; A61P25/28; A61P27/00; A61P35/00; C07D401/14
Domestic Patent References:
WO2002022607A1 | 2002-03-21 |
Foreign References:
CN1486310A | 2004-03-31 | |||
CN104903312A | 2015-09-09 |
Attorney, Agent or Firm:
NTD UNIVATION INTELLECTUAL PROPERTY AGENCY LTD. (CN)
Download PDF: